Cause-specific death after surgical resection for early-stage non-small-cell lung cancer
- PMID: 28950311
- DOI: 10.1093/ejcts/ezx274
Cause-specific death after surgical resection for early-stage non-small-cell lung cancer
Abstract
Objectives: Surgical resection is the recommended treatment for patients with early-stage non-small-cell lung cancer. However, it is believed that causes other than lung cancer can lead to death following surgical resection. Investigating the risk factors for overall mortality and analysing the specific causes of death may indicate the degree of influence of other causes of death.
Methods: We assessed individual risk factors affecting overall and cause-specific mortality in a Cox proportional hazards model in a cohort of patients with resected Stage I/II non-small-cell lung cancer (n = 756) from 2007 to 2015 in a tertiary university centre. The follow-up period ranged from 3 days to 9.3 years. Median survival time was 7.3 years (95% confidence interval 6.0-7.9). A few patients died of cardiovascular disease (n = 19) and were included in the group 'other cause'. In a competing risk model, we evaluated the risk factors for specific causes of death in patients dying of lung cancer and dying of non-lung cancer specific conditions.
Results: The overall survival was 94%, 62% and 50% at 1, 5 and 7 years, respectively. At the end of the follow-up period, the risk of having died of, respectively, lung cancer or other causes was 36% and 24%. The cumulative incidence of death of lung cancer increased continuously during the study. Risk factors predicting death of all causes and death of non-small-cell lung cancer were increasing age, severely reduced lung function, Eastern Cooperative Oncology Group Performance Status ≥2, preoperative examination without positron emission tomography/computed tomography, histological tumour diagnosis other than adenocarcinoma and squamous cell carcinoma and increasing disease stage. In patients dying of other causes, age, gender, body mass index, smoking and Eastern Cooperative Oncology Group Performance Status ≥2 affected the mortality rate.
Conclusions: The probability of having died of lung cancer continued to increase beyond 5 years after the operation. Surveillance of risk factors associated with an increased mortality rate should be considered in the postoperative follow-up examination after lung cancer resection.
Keywords: Cause-specific mortality; Competing risk; Lung cancer; Mortality; NSCLC; Survival; Thoracic oncology; Thoracic surgery.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
Similar articles
-
Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.J Cardiovasc Surg (Torino). 2007 Jun;48(3):375-83. J Cardiovasc Surg (Torino). 2007. PMID: 17505444
-
Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.Clin Lung Cancer. 2018 Mar;19(2):e195-e203. doi: 10.1016/j.cllc.2017.10.016. Epub 2017 Oct 28. Clin Lung Cancer. 2018. PMID: 29153966
-
Do women live longer following lung resection for carcinoma?Eur J Cardiothorac Surg. 2002 Feb;21(2):319-25. doi: 10.1016/s1010-7940(01)01114-9. Eur J Cardiothorac Surg. 2002. PMID: 11825743
-
Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review.Jpn J Clin Oncol. 2017 Jan;47(1):7-11. doi: 10.1093/jjco/hyw148. Epub 2016 Oct 20. Jpn J Clin Oncol. 2017. PMID: 27765813 Review.
-
Surgical management of early stage lung cancer.Semin Surg Oncol. 2000 Mar;18(2):124-36. doi: 10.1002/(sici)1098-2388(200003)18:2<124::aid-ssu6>3.0.co;2-n. Semin Surg Oncol. 2000. PMID: 10657914 Review.
Cited by
-
Comparative prognosis of long-term follow-up over 10 years and dropout from follow-up after resection of lung cancer.J Thorac Dis. 2024 Oct 31;16(10):6740-6751. doi: 10.21037/jtd-24-909. Epub 2024 Oct 30. J Thorac Dis. 2024. PMID: 39552871 Free PMC article.
-
Surgery offers survival advantage over radiotherapy in patients who are 80 years and older with Stage I and II NSCLC: A retrospective cohort study of 7,045 patients.Front Surg. 2022 Oct 4;9:1018320. doi: 10.3389/fsurg.2022.1018320. eCollection 2022. Front Surg. 2022. PMID: 36268213 Free PMC article.
-
Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non-small cell lung cancer.Thorac Cancer. 2022 Apr;13(7):947-955. doi: 10.1111/1759-7714.14329. Epub 2022 Feb 11. Thorac Cancer. 2022. PMID: 35150094 Free PMC article.
-
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.J Thorac Oncol. 2021 Jun;16(6):960-967. doi: 10.1016/j.jtho.2020.12.017. Epub 2021 Feb 1. J Thorac Oncol. 2021. PMID: 33539971 Free PMC article.
-
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.Mol Oncol. 2019 May;13(5):1166-1179. doi: 10.1002/1878-0261.12475. Epub 2019 Apr 10. Mol Oncol. 2019. PMID: 30854794 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical